Tendências na cirurgia de câncer de mama em pacientes de um serviço privado sob rastreio oportunístico
Palavras-chave:
neoplasias de mama, linfonodo sentinela, excisão de linfonodo, mastectomia segmentar, mastectomia simplesResumo
Objetivo: A pesquisa visa determinar a evolução do estadiamento e do tratamento cirúrgico em pacientes com câncer de mama em uma clínica privada, nos últimos 40 anos. Métodos: Estudo observacional descritivo retrospectivo, por meio da análise estatística dos prontuários de 2105 pacientes atendidas em clínica privada em Curitiba, Paraná, entre 1977 e 2017. Resultados: Dados analisados de 2.105 pacientes diagnosticadas com câncer de mama revelaram que, ao longo do tempo, as cirurgias radicais predominaram quando comparadas às cirurgias conservadoras. No entanto, quando analisadas proporcionalmente ao longo dos anos, é possível constatar uma inversão das modalidades cirúrgicas. Demonstrou-se que de 1977 a 2017, houve aumento de 273% do número das cirurgias conservadoras e queda de 45,5% das mastectomias. Associado a esse dado, notou-se diminuição do número de esvaziamento axilar e consequentemente de linfonodos sentinela positivos. Além disso, os tumores diagnosticados em fase inicial (T1) aumentaram ao longo dos anos. Conclusão: As pacientes tiveram um diagnóstico em estadiamento mais precoce da doença, proporcionando tratamentos cirúrgicos menos invasivos e, consequentemente, menor morbidade.
Downloads
Referências
Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin [Internet]. 2018 [acessado em 2 nov. 2018];68(6):394-424. Disponivel em: http://www.ncbi.nlm.nih. gov/pubmed/30207593. https://doi.org/10.3322/caac.21492
Instituto Nacional de Cancer. Ministerio da Saude. Tipos de cancer [Internet]. Instituto Nacional de Cancer; 2018 [acessado em 31 maio 2018]. Disponivel em: http://www2. inca.gov.br/wps/wcm/connect/tiposdecancer/site/home/ mama/cancer_mama
World Health Organization. Diagnosis and screeening [Internet]. World Health Organization [acessado em 01 nov. 2018]. Disponivel em: http://www.who.int/cancer/prevention/ diagnosis-screening/breast-cancer/en/
Alexander FE, Anderson TJ, Brown HK, Forrest AP, Hepburn W, Kirkpatrick AE, et al. 14 years of follow-up from the Edinburgh randomised trial of breast-cancer screening. Lancet [Internet]. 1999 [acessado em 26 nov. 2017];353(9168):1903-8. Disponivel em: http://www.ncbi.nlm.nih.gov/pubmed/10371567. https:// doi.org/10.1016/s0140-6736(98)07413-3
Shapiro S. Periodic screening for breast cancer: the HIP Randomized Controlled Trial. Health Insurance Plan. J Natl Cancer Inst Monogr [Internet]. 1997 [acessado em 26 nov. 2017];(22):27-30. Disponivel em: http://www.ncbi.nlm.nih.gov/ pubmed/9709271. https://doi.org/10.1093/jncimono/1997.22.27
Myers ER, Moorman P, Gierisch JM, Havrilesky LJ, Grimm LJ, Ghate S, et al. Benefits and Harms of Breast Cancer Screening - A systematic review. JAMA [Internet]. 2015 [acessado em 21 out. 2015];314(15):1615-34. Disponivel em: http://www. ncbi.nlm.nih.gov/pubmed/26501537. https://doi.org/10.1001/ jama.2015.13183
Tabar L, Vitak B, Chen TH, Yen AM, Cohen A, Tot T, et al. Swedish two-county trial: impact of mammographic screening on breast cancer mortality during 3 decades - with comments. Radiology [Internet]. 2011 [acessado em 02 nov. 2018];260(3):658-63. Disponivel em: http://www.ncbi.nlm.nih.gov/pubmed/21712474
Fisher B, Anderson S, Bryant J, Margolese R, Deutsch M, Fisher ER, et al. Twenty-Year Follow-Up of a Randomized Trial Comparing Total for the Treatment of Invasive Breast Cancer. N Engl J Med. 2002;347(16):1233-41. https://doi.org/10.1056/NEJMoa022152
Veronesi U, Cascinelli N, Mariani L, Greco M, Saccozzi R, Luini A, et al. Twenty-year follow-up of a randomized study comparing breastconserving surgery with radical mastectomy for early breast cancer. N Engl J Med [Internet]. 2002 [acessado em 2 nov. 2018];347(16):1227- 32. Disponivel em: http://www.nejm.org/doi/abs/10.1056/NEJMoa020989. https://doi.org/10.1056/NEJMoa020989
van Dongen JA, Voogd AC, Fentiman IS, Legrand C, Sylvester RJ, Tong D, et al. Long-term results of a randomized trial comparing breast-conserving therapy with mastectomy: European Organization for Research and Treatment of Cancer 10801 trial. J Natl Cancer Inst [Internet]. 2000 [acessado em 2 nov. 2018];92(14):1143-50. Disponivel em: http://www.ncbi.nlm.nih. gov/pubmed/10904087. https://doi.org/10.1093/jnci/92.14.1143
Urban C, Rietjens M. Oncoplastic and Reconstructive Breast Surgery. 1a ed. Italia: Springer-Verlag; 2013. p. 13-21.
Kuroda F, Urban C, Zucca-Matthes G, de Oliveira VM, Arana GH, Iera M, et al. Evaluation of Aesthetic and Quality-of-Life Results after Immediate Breast Reconstruction with Definitive Form- Stable Anatomical Implants. Plast Reconstr Surg [Internet]. 2016 [acessado em 7 jul. 2018];137(2):278e-86e. Disponivel em: http:// content.wkhealth.com/linkback/openurl?sid=WKPTLP:landing page&an=00006534-201602000-00005. https://doi.org/10.1097/01. prs.0000475746.17968.f4
Peiris L, Olson D, Kelly D. Oncoplastic and reconstructive breast surgery in Canada: breaking new ground in general surgical training. Can J Surg [Internet]. 2018 [acessado em 1o nov. 2018];61(5):294-9. Disponivel em: http://www.ncbi.nlm. nih.gov/pubmed/30246974. https://doi.org/10.1503/cjs.016717
Giuliano AE, Kirgan DM, Guenther JM, Morton DL. Lymphatic mapping and sentinel lymphadenectomy for breast cancer. Ann Surg [Internet]. 1994 [acessdao em 2 nov. 2018];220(3):391- 8; discussion 398-401. Disponivel em: http://www.ncbi.nlm. nih.gov/pubmed/8092905. https://doi.org/10.1097/00000658- 199409000-00015
Krag DN, Anderson SJ, Julian TB, Brown AM, Harlow SP, Costantino JP, et al. Sentinel-lymph-node resection compared with conventional axillary-lymph-node dissection in clinically node-negative patients with breast cancer: overall survival findings from the NSABP B-32 randomised phase 3 trial. Lancet Oncol [Internet]. 2010 [acessado em 2 nov. 2018];11(10):927-33. Disponivel em: http://linkinghub.elsevier.com/retrieve/pii/S1470204510702072. https://doi.org/10.1016/S1470-2045(10)70207-2
Mansel RE, Fallowfield L, Kissin M, Goyal A, Newcombe RG, Dixon JM, et al. Randomized Multicenter Trial of Sentinel Node Biopsy Versus Standard Axillary Treatment in Operable Breast Cancer: The ALMANAC Trial. JNCI J Natl Cancer Inst [Internet]. 2006 [acessado em 2 nov. 2018];98(9):599-609. Disponivel em: http://www.ncbi.nlm.nih.gov/pubmed/16670385. https://doi.org/10.1093/jnci/djj158
Giuliano AE, Hunt KK, Ballman KV, Beitsch PD, Whitworth PW, Blumencranz PW, et al. Axillary Dissection vs No Axillary Dissection in Women With Invasive Breast Cancer and Sentinel Node Metastasis. JAMA [Internet]. 2011 [acessado em 2 nov. 2018];305(6):569-75. Disponivel em: http://www.ncbi.nlm.nih.gov/pubmed/21304082. https://doi.org/10.1001/jama.2011.90
Donker M, van Tienhoven G, Straver ME, Meijnen P, van de Velde CJH, Mansel RE, et al. Radiotherapy or surgery of the axilla after a positive sentinel node in breast cancer (EORTC 10981-22023 AMAROS): a randomised, multicentre, open-label, phase 3 non-inferiority trial. Lancet Oncol [Internet]. 2014 [acessado em 2 nov. 2018];15(12):1303-10. Disponivel em: https://linkinghub.elsevier.com/retrieve/pii/S1470204514704607. https://doi.org/10.1016/S1470-2045(14)70460-7
Yu K-D, Di G-H, Wu J, Lu J-S, Shen K-W, Shen Z-Z, et al. Development and trends of surgical modalities for breast cancer in China: a review of 16-year data. Ann Surg Oncol [Internet]. 2007 [acessdao em 2 nov. 2018];14(9):2502-9. Disponivel em: http://www.springerlink.com/index/10.1245/s10434-007-9436-2. https://doi.org/10.1245/s10434-007-9436-2
Kang SY, Kim YS, Kim Z, Kim H-Y, Lee SK, Jung K-W, et al. Basic Findings Regarding Breast Cancer in Korea in 2015: Data from a Breast Cancer Registry. J Breast Cancer [Internet]. 2018 [acessado em 1o nov. 2018];21(1):1-10. Disponivel em: http://www.ncbi.nlm.nih.gov/pubmed/29628978. https://doi.org/10.4048/jbc.2018.21.1.1
National Accreditation Program for Breast Centers. 2018 Breast Cancer Standards Manual. Chicago: National Accreditation Program for Breast Centers; 2018.
Veronesi U, Paganelli G, Viale G, Luini A, Zurrida S, Galimberti V, et al. A Randomized Comparison of Sentinel-Node Biopsy with Routine Axillary Dissection in Breast Cancer. N Engl J Med [Internet]. 2003 [acessado em 4 nov. 2018];349(6):546- 53. Disponivel em: http://www.ncbi.nlm.nih.gov/pubmed/12904519. https://doi.org/10.1056/NEJMoa012782
Zavagno G, De Salvo GL, Scalco G, Bozza F, Barutta L, Del Bianco P, et al. A Randomized clinical trial on sentinel lymph node biopsy versus axillary lymph node dissection in breast cancer: results of the Sentinella/GIVOM trial. Ann Surg [Internet]. 2008 [acessado em 4 nov. 2018];247(2):207-13. Disponivel em: https://insights.ovid.com/crossref?an=00000658-200802000-00001. https://doi.org/10.1097/SLA.0b013e31812e6a73
Galimberti V, Cole BF, Zurrida S, Viale G, Luini A, Veronesi P, et al. Axillary dissection versus no axillary dissection in patients with sentinel-node micrometastases (IBCSG 23–01): a phase 3 randomised controlled trial. Lancet Oncol [Internet]. 2013 [acessado em 4 nov. 2018];14(4):297-305. Disponivel em: http://www.ncbi.nlm.nih.gov/pubmed/23491275. https://doi.org/10.1016/S1470-2045(13)70035-4
Hunt KK, Yi M, Mittendorf EA, Guerrero C, Babiera GV, Bedrosian I, et al. Sentinel Lymph Node Surgery After Neoadjuvant Chemotherapy is Accurate and Reduces the Need for Axillary Dissection in Breast Cancer Patients. Ann Surg [Internet]. 2009 [acessado em 4 nov. 2018];250(4):558-66. Disponivel em: http://www.ncbi.nlm.nih.gov/pubmed/19730235. https://doi.org/10.1097/SLA.0b013e3181b8fd5e
Bjurstam NG, Bjorneld LM, Duffy SW. Updated results of the Gothenburg Trial of Mammographic Screening. Cancer [Internet]. 2016 [acessado em 26 nov. 2017];122(12):1832- 5. Disponivel em: http://www.ncbi.nlm.nih.gov/pubmed/27061821. https://doi.org/10.1002/cncr.29975
Oeffinger KC, Fontham ETH, Etzioni R, Herzig A, Michaelson JS, Shih Y-CT, et al. Breast Cancer Screening for Women at Average Risk: 2015 Guideline Update From the American Cancer Society. JAMA [Internet]. 2015 [acessado em 26 nov. 2017];314(15):1599-614. Disponivel em: http://jama.jamanetwork.com/article.aspx?doi=10.1001/jama.2015.12783. https://doi.org/10.1001/jama.2015.12783
Instituto Nacional de Cancer. Diretrizes para a deteccao precoce do cancer de mama no Brasil. Rio de Janeiro: Instituto Nacional de Cancer; 2015.
Urban LABD, Chala LF, Di Pace Bauab S, Schaefer MB, dos Santos RP, Maranhao NMDA, et al. Recomendacoes do Colegio Brasileiro de Radiologia e Diagnostico por Imagem, da Sociedade Brasileira de Mastologia e da Federacao Brasileira das Associacoes de Ginecologia e Obstetricia para o rastreamento do cancer de mama. Radiol Bras [Internet]. 2017 [acessado em 4 nov. 2018];50(4):244-9. Disponivel em: http://dx.doi.org/10.1590/0100-3984.2017-0069
Simon S, Bines J, Barrios C, Nunes J, Gomes E, Pacheco F, et al. Clinical Characteristics and Outcome of Treatment of Brazilian Women with Breast Cancer Treated at Public and Private Institutions – The AMAZONE Project of the Brazilian Breast Cancer Study Group (GBECAM). Cancer Res [Internet]. 2009 [acessado em 4 nov. 2018];69(24 Supl.):3082. Disponivel em: http://cancerres.aacrjournals.org/lookup/doi/10.1158/0008-5472.SABCS-09-3082. http://dx.doi.org/10.1158/0008-5472.SABCS-09-3082
Freitas R Jr., Siqueira LB, Carrijo EN dos A, Lacerda RP, Paulinelli RR, Rahal RMS, et al. Temporal variation of breast cancer surgical treatment in a university hospital in Brazil’s Central West region. Rev Col Bras Cir [Internet]. 2013 [acessado em 4 nov. 2018];40(3):180-5. Disponivel em: http://www.ncbi.nlm.nih.gov/pubmed/23912363
NHS Digital. NHS Breast screening programme, England 2010- 11. Inglaterra: NHS Digital; 2012.
Freitas-Junior R, Gagliato DM, Moura Filho JWC, Gouveia PA, Rahal RMS, Paulinelli RR, et al. Trends in breast cancer surgery at Brazil’s public health system. J Surg Oncol [Internet]. 2017 [acessado em 28 jul. 2018];115(5):544-9. Disponivel em: http://www.ncbi.nlm.nih.gov/pubmed/28168857. https://doi.org/10.1002/jso.24572
Nystrom L, Rutqvist LE, Wall S, Lindgren A, Lindqvist M, Ryden S, et al. Breast cancer screening with mammography: overview of Swedish randomised trials. Lancet (London, England) [Internet]. 1993 [acessado em 4 nov. 2018];341(8851):973-8. Disponivel em: http://www.ncbi.nlm.nih.gov/pubmed/8096941. https://doi.org/10.1016/0140-6736(93)91067-v
DeSantis CE, Bray F, Ferlay J, Lortet-Tieulent J, Anderson BO, Jemal A. International Variation in Female Breast Cancer Incidence and Mortality Rates. Cancer Epidemiol Biomarkers Prev [Internet]. 2015 [acessado em 4 nov. 2018];24(10):1495-506. Disponivel em: http://www.ncbi.nlm.nih.gov/pubmed/26359465. https://doi.org/10.1158/1055-9965.EPI-15-0535
Downloads
Publicado
Como Citar
Edição
Seção
Licença
Copyright (c) 2019 Tatiane Aparecida Oenning, Juliana Lopes Correa, Júlia Helena Alves Fortes Martins, Michelli Esteves de Souza, João Pedro Penteado Barbosa, Maíra Teixeira Dória, Luiz Henrique Furlan, Bernardo Sobreiro, Cícero Úrban, Iris Rabinovich, Karina Furlan, Cleverton Spautz, Rubens Silveira
Este trabalho está licenciado sob uma licença Creative Commons Attribution 4.0 International License.
